[144] Intuitive Surgical Inc. SEC Filing

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) filed a Form 144 reporting a proposed sale of 336 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate sale date of 09/03/2025. The filing lists an aggregate market value of $157,956.96 and shows 358,476,506 shares outstanding. The shares to be sold were originally issued as restricted stock: 102 shares acquired 04/27/2023 and 234 shares acquired 04/25/2024; payment is listed as Not Applicable. The filing reports no securities sold during the past three months. Several administrative fields (filer CIK/CCC and issuer contact details) are not populated in the provided text.

Positive

• Filing documents compliance with Rule 144 and publicly discloses the proposed insider sale
• Acquisition history for the shares is provided (dates and amounts), improving traceability

Negative

• None.

Insights

Financial Analyst

TL;DR: Small insider sale filing; amount is negligible relative to total shares outstanding and is primarily a compliance disclosure.

The Form 144 notifies the market of a proposed sale of 336 restricted shares with an aggregate value of $157,956.96, scheduled via a Morgan Stanley broker on NASDAQ. Given the issuer's outstanding share count of 358,476,506, the position represents an immaterial fraction of equity outstanding. There are no reported sales in the prior three months. From an analytical standpoint, this filing is routine disclosure under Rule 144 and does not, by itself, signal a material change to the company’s capital structure or investor base.

Corporate Governance Expert

TL;DR: The filing reflects standard insider compliance; documentation of restricted stock origins is appropriate and complete in the tables provided.

The notice records that the shares were acquired as restricted stock from the issuer on two dates and specifies the broker and planned sale date, which aligns with regulatory expectations for transparency about insider dispositions. The absence of reported sales in the prior three months and the clear listing of acquisition dates and amounts support traceability. Some issuer and filer contact fields are blank in the extract, which limits administrative completeness but does not alter the substantive disclosure about the securities to be sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	336	157956.96	358476506	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2023	Restricted Stock	ISSUER			102	04/27/2023	Not Applicable
Common	04/25/2024	Restricted Stock	ISSUER			234	04/25/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ISRG Form 144 report?

The filing reports a proposed sale of 336 common shares via Morgan Stanley Smith Barney LLC on 09/03/2025 on the NASDAQ, with an aggregate market value of $157,956.96.

How were the shares being sold acquired according to the filing?

The shares were acquired as restricted stock from the issuer: 102 shares on 04/27/2023 and 234 shares on 04/25/2024.

Does the Form 144 show any securities sold in the past three months for this account?

The filing states Nothing to Report for securities sold during the past three months.

What is the issuer’s outstanding share count listed in the filing?

The document lists 358,476,506 shares outstanding.

Which broker is named to execute the sale in the Form 144?

The named broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.